Gridai Technologies Corp (GRDX)

$4.42 -0.18 (-3.91%)
Market Cap 30.60M
Revenue (ttm) 40,000.00
Net Income (ttm) -6.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15,975.00%
Debt to Equity Ratio 0.01
Volume 72,500
Avg Vol 131,478
Day's Range N/A - N/A
Shares Out 6.65M
Stochastic %K 6%
Beta 1.80
Analysts Hold
Price Target N/A

Company Profile

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Industry: Biotechnology
Sector: Healthcare
Address:
91 George St, Edinburgh, United Kingdom
MadStockAlerts1
MadStockAlerts1 Jun. 22 at 4:39 AM
$GRDX is building something here. The 50-day just crossed above the 200-day, a golden cross, and that is the kind of signal the big boys watch closely. One bounce can fade. A trend with the moving averages lining up tells a different story.
0 · Reply
topstockalerts
topstockalerts Jun. 19 at 9:31 PM
$GRDX this is starting to look like a trend, not just a bounce
0 · Reply
flabb
flabb Jun. 15 at 12:08 PM
Limit orders Filled this morning $GRDX 5.28 $PLUG 2.87 $SOUN 7.19 7.18 7.16 with limit orders in at 7.l2 - 7.01 $AMC 2.39 added with limit order 2.34 and lower in. More to come.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 10 at 7:31 AM
$GRDX Outstanding article that hits the mark on GRDX's current state. So if you want to refresh your GRDX insights or learn about GRDX from scratch, this is a must read. https://everyticker.com/quote/GRDX/analysis/gridai-s-last-stand-a-biotech-s-hail-mary-into-the-ai-power-crisis-nasdaq-grdx
0 · Reply
red75
red75 Jun. 5 at 8:17 PM
$GRDX interested
0 · Reply
topstockalerts
topstockalerts Jun. 5 at 1:35 AM
$GRDX this is the sort of action that sneaks onto your top list
0 · Reply
SaccaSpuds
SaccaSpuds Jun. 4 at 11:33 AM
$GRDX let’s get this puppy to $50.
0 · Reply
Pokingholes
Pokingholes Jun. 2 at 3:16 AM
$GRDX Great Play JLCw. I picked some up shortly after you alerted on this puppy at an average of 2.20. Your absolutely killing it with these plays. Only regret i have is not buying more. Not sure how you’re coming up with this stuff. Did you figure out how to time travel or what?
0 · Reply
JLCw
JLCw Jun. 1 at 9:56 PM
$GRDX 🔥🤝
1 · Reply
victoria888888888
victoria888888888 May. 31 at 11:46 PM
$GRDX
0 · Reply
Latest News on GRDX
GridAI files to sell 6.2M shares of common stock for holders

2026-05-28T10:27:56.000Z - 4 weeks ago

GridAI files to sell 6.2M shares of common stock for holders

GridAI Technologies Corp. to Present at the Market Movers Investor Summit

Apr 29, 2026, 1:30 PM EDT - 2 months ago

GridAI Technologies Corp. to Present at the Market Movers Investor Summit

GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing

Apr 28, 2026, 5:20 PM EDT - 2 months ago

GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing

GridAI identifies Amp Z as previously announced AI data center developer

2026-03-04T13:22:34.000Z - 4 months ago

GridAI identifies Amp Z as previously announced AI data center developer

GridAI Technologies Corp. Identifies Amp Z as Previously Announced Stealth Hyperscaler AI Data Center Developer

Mar 4, 2026, 8:00 AM EST - 4 months ago

GridAI Technologies Corp. Identifies Amp Z as Previously Announced Stealth Hyperscaler AI Data Center Developer

GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

Feb 4, 2026, 8:45 AM EST - 5 months ago

GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

GridAI appoints Healy as Executive Chairman of Grid AI Corp.

2026-02-04T13:21:10.000Z - 5 months ago

GridAI appoints Healy as Executive Chairman of Grid AI Corp.

GridAI engages IBN for corporate communications strategy

2026-01-26T13:41:35.000Z - 5 months ago

GridAI engages IBN for corporate communications strategy

GridAI and the New Operating Reality of the Electric Grid

Jan 14, 2026, 8:00 AM EST - 5 months ago

GridAI and the New Operating Reality of the Electric Grid

GridAI's Role at the Center of Grid Intelligence Economics

Jan 13, 2026, 8:20 AM EST - 5 months ago

GridAI's Role at the Center of Grid Intelligence Economics

GridAI and the Financial Mechanics of Grid Intelligence

Jan 12, 2026, 10:00 AM EST - 5 months ago

GridAI and the Financial Mechanics of Grid Intelligence

GridAI appoints Marshall Chapin as CEO of energy-orchestration subsidiary

2025-12-04T15:06:28.000Z - 7 months ago

GridAI appoints Marshall Chapin as CEO of energy-orchestration subsidiary

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

Nov 28, 2025, 8:00 AM EST - 7 months ago

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

Nov 19, 2025, 8:45 AM EST - 7 months ago

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Nov 13, 2025, 8:35 AM EST - 8 months ago

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Nov 6, 2025, 8:45 AM EST - 8 months ago

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)

Oct 30, 2025, 9:00 AM EDT - 8 months ago

Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)

Entero Regains Nasdaq Compliance With Grid AI Acquisition

Oct 30, 2025, 6:00 AM EDT - 8 months ago

Entero Regains Nasdaq Compliance With Grid AI Acquisition

Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid

Oct 16, 2025, 8:40 AM EDT - 9 months ago

Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid

From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)

Oct 14, 2025, 11:00 AM EDT - 9 months ago

From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)

Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

Oct 14, 2025, 8:00 AM EDT - 9 months ago

Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI

Oct 1, 2025, 4:05 PM EDT - 9 months ago

ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI

ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand

Oct 1, 2025, 8:30 AM EDT - 9 months ago

ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand

Entero Therapeutics, Inc. Announces Reverse Stock Split

Aug 14, 2025, 9:15 AM EDT - 11 months ago

Entero Therapeutics, Inc. Announces Reverse Stock Split

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

Aug 11, 2025, 7:30 AM EDT - 11 months ago

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

FluroTech Ltd. Announces Change in Directors

Jun 13, 2025, 10:46 AM EDT - 1 year ago

FluroTech Ltd. Announces Change in Directors

MMA

Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC

Mar 24, 2025, 10:51 PM EDT - 1 year ago

Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC

Entero Therapeutics Appoints Richard Paolone as CEO

Feb 14, 2025, 4:00 PM EST - 1 year ago

Entero Therapeutics Appoints Richard Paolone as CEO

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

Feb 7, 2025, 3:22 PM EST - 1 year ago

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders

Nov 15, 2024, 8:00 AM EST - 1 year ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders

PULM

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc. - ENTO

Nov 14, 2024, 6:50 PM EST - 1 year ago

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc. - ENTO

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Nov 13, 2024, 7:00 AM EST - 1 year ago

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Oct 8, 2024, 5:00 AM EDT - 1 year ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS ONCO VRNA

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

Aug 23, 2024, 5:00 PM EDT - 1 year ago

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

Entero Therapeutics' Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

Jul 31, 2024, 7:00 AM EDT - 2 years ago

Entero Therapeutics' Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

Jun 27, 2024, 6:00 AM EDT - 2 years ago

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

May 22, 2024, 7:00 AM EDT - 2 years ago

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

May 20, 2024, 7:00 AM EDT - 2 years ago

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

MadStockAlerts1
MadStockAlerts1 Jun. 22 at 4:39 AM
$GRDX is building something here. The 50-day just crossed above the 200-day, a golden cross, and that is the kind of signal the big boys watch closely. One bounce can fade. A trend with the moving averages lining up tells a different story.
0 · Reply
topstockalerts
topstockalerts Jun. 19 at 9:31 PM
$GRDX this is starting to look like a trend, not just a bounce
0 · Reply
flabb
flabb Jun. 15 at 12:08 PM
Limit orders Filled this morning $GRDX 5.28 $PLUG 2.87 $SOUN 7.19 7.18 7.16 with limit orders in at 7.l2 - 7.01 $AMC 2.39 added with limit order 2.34 and lower in. More to come.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 10 at 7:31 AM
$GRDX Outstanding article that hits the mark on GRDX's current state. So if you want to refresh your GRDX insights or learn about GRDX from scratch, this is a must read. https://everyticker.com/quote/GRDX/analysis/gridai-s-last-stand-a-biotech-s-hail-mary-into-the-ai-power-crisis-nasdaq-grdx
0 · Reply
red75
red75 Jun. 5 at 8:17 PM
$GRDX interested
0 · Reply
topstockalerts
topstockalerts Jun. 5 at 1:35 AM
$GRDX this is the sort of action that sneaks onto your top list
0 · Reply
SaccaSpuds
SaccaSpuds Jun. 4 at 11:33 AM
$GRDX let’s get this puppy to $50.
0 · Reply
Pokingholes
Pokingholes Jun. 2 at 3:16 AM
$GRDX Great Play JLCw. I picked some up shortly after you alerted on this puppy at an average of 2.20. Your absolutely killing it with these plays. Only regret i have is not buying more. Not sure how you’re coming up with this stuff. Did you figure out how to time travel or what?
0 · Reply
JLCw
JLCw Jun. 1 at 9:56 PM
$GRDX 🔥🤝
1 · Reply
victoria888888888
victoria888888888 May. 31 at 11:46 PM
$GRDX
0 · Reply
STACKD0E
STACKD0E May. 31 at 10:00 PM
$RXO $SIDU $SPAI $GRDX 🙃✨️
0 · Reply
JLCw
JLCw May. 30 at 9:24 AM
$GRDX 🔥
1 · Reply
JeffingAround
JeffingAround May. 27 at 1:45 PM
$GRDX
0 · Reply
Tester87100
Tester87100 May. 26 at 1:45 PM
$GRDX
0 · Reply
Flarelords
Flarelords May. 25 at 1:45 PM
$GRDX
1 · Reply
LuckyInvested
LuckyInvested May. 24 at 1:45 PM
$GRDX
0 · Reply
Cultler
Cultler May. 23 at 1:45 PM
$GRDX
0 · Reply
JLCw
JLCw May. 22 at 6:16 PM
$GRDX just hit $5 🤌🤌🤌
2 · Reply
Fidely
Fidely May. 22 at 1:45 PM
$GRDX
0 · Reply
Tech4lyfe
Tech4lyfe May. 21 at 1:45 PM
$GRDX
0 · Reply
ug_mine_engineer
ug_mine_engineer May. 20 at 8:09 PM
$GRDX Does anyone know what this company is?
1 · Reply
Eatmon
Eatmon May. 20 at 1:45 PM
$GRDX
0 · Reply